Literature DB >> 16094754

Proteasome inhibitor for treatment of multiple myeloma.

Khabir Ahmad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16094754     DOI： 10.1016/s1470-2045(05)70264-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Proteasome functional insufficiency in cardiac pathogenesis.

Authors:  Xuejun Wang; Jie Li; Hanqiao Zheng; Huabo Su; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

Review 2.  Ubiquitin receptors and protein quality control.

Authors:  Xuejun Wang; Erin J M Terpstra
Journal:  J Mol Cell Cardiol       Date:  2012-10-06       Impact factor: 5.000

3.  Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics.

Authors:  Liewei Wang; Shaji Kumar; Brooke L Fridley; Krishna R Kalari; Irene Moon; Linda L Pelleymounter; Michelle A T Hildebrandt; Anthony Batzler; Bruce W Eckloff; Eric D Wieben; Philip R Greipp
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

4.  Inhibition of Nek2 by small molecules affects proteasome activity.

Authors:  Lingyao Meng; Kent Carpenter; Alexis Mollard; Hariprasad Vankayalapati; Steven L Warner; Sunil Sharma; Guido Tricot; Fenghuang Zhan; David J Bearss
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.